About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
More Lab Notes From This Project
Browse Other Projects on Experiment
The Health Justice Project: Using digital stories to address health disparities as a social justice issue
The purpose of this project is to examine the link between racial and social injustice based on one's minority...